Why the study?
Epicardial fat is thought to be a cardiovascular risk factor, but there are no established methods for measuring its parameters.
Epicardial fat is a relevant cardiometabolic risk marker in obese patients, and transthoracic echocardiography is proposed as an accessible method for its measurement.
Supports epicardial fat as a modifiable risk factor in hypertension; leaves open validation of echocardiography and targeted therapies.
Epicardial fat (EF) is thought to be a cardiovascular risk factor, it has attracted a great interest from researchers and is relevant to study. The article presents a review on EF influence on cardiovascular system and metabolic parameters, as well as new therapeutic approaches to modify EF volume. There are no established methods for EF parameters measurement at present. The use of transthoracic echocardiography which is a simple, accessible, and informative procedure is suggested as one of these methods
No takes yet. Share an insight, caveat, or question.
Blinova et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: